Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Womens Imaging: Page 360
AMA: Women should be eligible for mammo screening at 40
By
AuntMinnie.com staff writers
The American Medical Association (AMA) voted on June 18 at its annual policymaking meeting to adopt the policy that women should be eligible for screening mammography at age 40.
June 18, 2012
Waiting period expires for Hologic's Gen-Probe buy
By
AuntMinnie.com staff writers
Women's imaging vendor Hologic said that the initial 30-day waiting period required under the Hart-Scott-Rodino Act has expired without a request for additional information from the Federal Trade Commission.
June 18, 2012
FFDM fails to lower missed-cancer percentage, study shows
By
Kate Madden Yee
,
Erik L. Ridley
Full-field digital mammography (FFDM) does not improve upon the performance of film-screen mammography, at least in terms of the percentage of missed interval and screening-detected cancers, Norwegian researchers reported in a study published online June 14 in
Radiology
.
June 17, 2012
Report ties keepsake ultrasound to fetal gender tests in Canada
By
Rosemary Frei
An investigative report has caused a stir in Canada after it revealed that keepsake ultrasound clinics are willing to provide the gender of fetuses before 20 weeks of gestation. This is early enough for women to request an abortion and feeds into the phenomenon of female feticide in some immigrant communities in Canada.
June 14, 2012
ATA advises thyroid collars not needed for mammography
By
AuntMinnie.com staff writers
Thyroid collars are not need for mammograms, according to new guidelines on minimizing radiation dose issued on June 13 by the American Thyroid Association (ATA). However, the association advised a number of other steps to minimize unnecessary exposure to radiation from medical and dental imaging procedures, such as the use of collars for dental x-rays.
June 13, 2012
SNM: NaF finds more breast cancer bone metastases than FDG
By
Wayne Forrest
MIAMI BEACH, FL - Sodium fluoride (NaF) PET/CT detected bone metastases in patients with breast cancer more effectively than FDG, especially in cases of restaging, according to a study presented this week at the Society of Nuclear Medicine (SNM) annual meeting.
June 12, 2012
Study eyes breast cancer risk from imaging
By
AuntMinnie.com staff writers
Breast cancer risk can be lowered by avoiding unnecessary imaging, according to an article published online June 11 in the
Archives of Internal Medicine
.
June 11, 2012
Matakina partners with MRS
By
AuntMinnie.com staff writers
Matakina International and Mammography Reporting System (MRS) have signed an agreement for MRS to provide users of the MRS7 reporting system with the ability to utilize Matakina's Volpara breast density software scores in an updated user interface.
June 6, 2012
Intelerad launches IntelePACS tomo module
By
AuntMinnie.com staff writers
PACS vendor Intelerad Medical Systems announced it has launched a digital breast tomosynthesis module for its IntelePACS software.
June 6, 2012
Study finds new imaging protocol cuts MBI dose by over half
By
Wayne Forrest
Mayo Clinic researchers have developed a modified protocol for low-dose molecular breast imaging (MBI) that cuts radiation dose by more than half. They have also developed an experimental technique that reduces dose to as little as 20% of what's currently used, according to two studies in the June issue of
Medical Physics
.
June 6, 2012
Delayed diagnosis most common complaint in breast imaging suits
By
Kate Madden Yee
Delay in diagnosis is the most common complaint in breast imaging malpractice litigation, say London researchers in the July issue of
Clinical Radiology
. Breast microcalcification is the most often missed mammographic sign, according to the group.
June 4, 2012
GE, Affibody to develop PET imaging agent
By
AuntMinnie.com staff writers
GE Healthcare and Swedish biopharmaceutical company Affibody are collaborating on the development of a HER2-targeted PET imaging agent for patients with breast or gastric cancer.
June 4, 2012
Previous Page
Page 360 of 692
Next Page